Skip to main content
Log in

Basal serum pituitary hormone levels and outcome of in vitro fertilization utilizing a flare nasal gonadotropin releasing hormone agonist and fixed low-dose follicle-stimulating hormone/human menopausal gonadotropin regimen

  • Clinical Assisted Reproduction
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Day 2 serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are prognostic indicators in treatment with in vitro fertilization (IVF) and FSH is especially useful in predicting the ovarian response to superovulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Medical Research International, Society for Assisted Reproductive Technology (SART), The American Fertility Society: In-vitro fertilization-embryo transfer (IVF-ET) in the United States: 1990 results from the IVF-ET registry. Fertil Steril 1992;57:15–24

    Google Scholar 

  2. Tanbo T, Dale PO, Abyholm T, Stokke KT: Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate/human menopausal gonadotrophin-stimulated cycles for in-vitro fertilization. Hum Reprod 1989;4:647–650.

    PubMed  Google Scholar 

  3. Fénichel P, Donzeau M, Grimaldi M, Gillet J-Y, Olivero J-F, Harter M: Predictive value of hormonal profiles before stimulation for in vitro fertilization. Fertil Steril 1989;51:845–854

    PubMed  Google Scholar 

  4. Muasher SJ, Ellis LM, Oehninger S, Lui HC, Simonetti S, Jones GS, Matta J, Rosenwaks Z: The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298–307

    PubMed  Google Scholar 

  5. Scott RT, Oehninger S, Toner JP, Robinson S, Muasher SJ, Rosenwaks Z: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651–654

    PubMed  Google Scholar 

  6. Toner JP, Philput CB, Jones GS, Muasher SJ: Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784–791

    PubMed  Google Scholar 

  7. Khalifa E, Toner JP, Muasher SJ, Acosta AA: Significance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization. Fertil Steril 1992;57:835–839

    PubMed  Google Scholar 

  8. Hughes EG, King C, Wood EC: A prospective study of prognostic factors in in vitro fertilization and embryo transfer. Fertil Steril 1989;51:838–843

    PubMed  Google Scholar 

  9. Lachenbruch PA: Discriminant Analysis. New York, Hafner Press, 1975

    Google Scholar 

  10. SPSS/PC + Advanced Statistics V2.0 for the IBM PC/XT/AT and PS/2

  11. Baird DT, VanLook PFA, Hunter WM: Classification of abnormal patterns of gonadotrophin release in women. Clin Obstet Gynaecol 1976;3:505–513

    PubMed  Google Scholar 

  12. Gindoff PR, Jewelewicz R: Reproductive potential in the older woman. Fertil Steril 1986;46:989–1001

    PubMed  Google Scholar 

  13. Stanger JD, Yovich JL: Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynecol 1985;92:385–393

    Google Scholar 

  14. Nayudu PL, Lopata A, Gook DA, Johnston WIH, Hepworth G: Prediction of outcome in human in vitro fertilization based on follicular and stimulation response variables. Fertil Steril 1989;51:117–125

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chan, Y.F., Ho, P.C., So, W.W.K. et al. Basal serum pituitary hormone levels and outcome of in vitro fertilization utilizing a flare nasal gonadotropin releasing hormone agonist and fixed low-dose follicle-stimulating hormone/human menopausal gonadotropin regimen. J Assist Reprod Genet 10, 251–254 (1993). https://doi.org/10.1007/BF01204937

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01204937

Key words

Navigation